Gyeong Hoon Kang Selected Research

Microsatellite Instability

3/2022	Comprehensive clinicopathologic, molecular, and immunologic characterization of colorectal carcinomas with loss of three intestinal markers, CDX2, SATB2, and KRT20.
12/2021	NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
12/2021	Genomic and transcriptomic characterization of heterogeneous immune subgroups of microsatellite instability-high colorectal cancers.
1/2021	Targeted next-generation sequencing-based detection of microsatellite instability in colorectal carcinomas.
1/2021	Differential immune microenvironmental features of microsatellite-unstable colorectal cancers according to Fusobacterium nucleatum status.
9/2020	Immune landscape and biomarkers for immuno-oncology in colorectal cancers.
1/2019	p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
1/2019	Prognostic Impact of Fusobacterium nucleatum Depends on Combined Tumor Location and Microsatellite Instability Status in Stage II/III Colorectal Cancers Treated with Adjuvant Chemotherapy.
12/2017	Dominant high expression of wild-type HSP110 defines a poor prognostic subgroup of colorectal carcinomas with microsatellite instability: a whole-section immunohistochemical analysis.
9/2017	Intratumoral Fusobacterium nucleatum abundance correlates with macrophage infiltration and CDKN2A methylation in microsatellite-unstable colorectal carcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gyeong Hoon Kang Research Topics

Disease

72	Neoplasms (Cancer) 03/2022 - 02/2002
59	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 02/2002
28	Microsatellite Instability 03/2022 - 02/2002
15	Stomach Neoplasms (Stomach Cancer) 01/2019 - 06/2002
14	Adenoma (Adenomas) 12/2021 - 04/2003
10	Carcinogenesis 12/2021 - 07/2004
8	Colonic Neoplasms (Colon Cancer) 03/2022 - 04/2013
8	Rectal Neoplasms (Rectal Cancer) 01/2021 - 08/2011
8	Carcinoma (Carcinomatosis) 05/2015 - 07/2003
7	Neoplasm Metastasis (Metastasis) 01/2020 - 08/2012
6	Hepatocellular Carcinoma (Hepatoma) 12/2014 - 12/2003
6	Adenocarcinoma 08/2010 - 12/2003
5	Polyps 12/2021 - 12/2014
4	Cholangiocarcinoma 08/2017 - 09/2002
4	Lymphatic Metastasis 01/2015 - 06/2002
4	Gastritis 06/2010 - 04/2003
3	Infections 01/2017 - 05/2008
3	Body Weight (Weight, Body) 10/2015 - 11/2010
3	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2012 - 08/2009
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2007 - 01/2005
2	Neonatal hemochromatosis 03/2020 - 06/2016
2	Margins of Excision 07/2019 - 12/2013
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 11/2018 - 09/2017
2	Necrosis 05/2017 - 09/2015
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 03/2016 - 08/2014
2	Hyperplasia 06/2015 - 01/2008
2	Lung Neoplasms (Lung Cancer) 05/2013 - 01/2012
2	Breast Neoplasms (Breast Cancer) 02/2012 - 11/2010
2	Neoplasms, Cystic, Mucinous, and Serous 01/2012 - 08/2009
2	Non-alcoholic Fatty Liver Disease 11/2010 - 10/2009
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2009 - 01/2004
2	Hypoxia (Hypoxemia) 10/2008 - 01/2004
2	Prostatic Neoplasms (Prostate Cancer) 01/2008 - 02/2004
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2006 - 05/2006
2	Metaplasia 05/2003 - 04/2003
1	Tertiary Lymphoid Structures 12/2021
1	Fibrosis (Cirrhosis) 12/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2021
1	Crohn Disease (Crohn's Disease) 06/2020
1	Pediatric Crohn's disease 06/2020

Drug/Important Bio-Agent (IBA)

37	Calcibiotic Root Canal SealerIBA 03/2022 - 12/2009
18	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2006
14	Biomarkers (Surrogate Marker)IBA 06/2021 - 09/2002
11	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2004
10	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2019 - 06/2011
9	MucinsIBA 07/2020 - 02/2002
7	hydrogen sulfite (bisulfite)IBA 01/2022 - 07/2003
4	Cadherins (E-Cadherin)IBA 01/2020 - 09/2002
4	ParaffinIBA 01/2019 - 05/2004
4	EnzymesIBA 12/2017 - 01/2005
4	Indicators and Reagents (Reagents)IBA 05/2017 - 01/2006
4	Fluorouracil (Carac)FDA LinkGeneric 01/2016 - 04/2013
4	Leucovorin (Folinic Acid)FDA Link 01/2016 - 04/2013
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2012 - 09/2007
3	Messenger RNA (mRNA)IBA 03/2022 - 01/2017
3	Phosphotransferases (Kinase)IBA 12/2021 - 10/2006
3	Formaldehyde (Formol)FDA Link 01/2019 - 05/2004
3	Phenobarbital (Luminal)FDA Link 05/2017 - 02/2012
3	Small Interfering RNA (siRNA)IBA 11/2015 - 08/2008
3	AnnexinsIBA 09/2015 - 11/2014
3	antineoplaston A10 (A 10)IBA 09/2015 - 11/2014
2	Transaminases (Aminotransferases)IBA 12/2021 - 10/2009
2	Pharmaceutical PreparationsIBA 12/2021 - 11/2010
2	Circulating Tumor DNAIBA 11/2021 - 01/2020
2	Cell-Free Nucleic AcidsIBA 12/2020 - 01/2020
2	B7-H1 AntigenIBA 09/2020 - 12/2017
2	Mitogen-Activated Protein KinasesIBA 01/2020 - 04/2013
2	LigandsIBA 09/2018 - 05/2018
2	regorafenibIBA 05/2017 - 01/2015
2	Biological ProductsIBA 01/2017 - 12/2014
2	CateninsIBA 01/2017 - 08/2014
2	RNA (Ribonucleic Acid)IBA 01/2017 - 05/2004
2	Epithelial Cell Adhesion MoleculeIBA 03/2016 - 08/2014
2	LipidsIBA 07/2013 - 10/2009
2	UbiquitinIBA 05/2013 - 10/2008
2	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2013 - 10/2008
2	Decitabine FDA Link 06/2012 - 08/2008
2	trichostatin A (A 300)IBA 06/2012 - 08/2008
2	Estrogen ReceptorsIBA 11/2010 - 10/2007
2	ElementsIBA 10/2010 - 10/2009
2	Tumor Biomarkers (Tumor Markers)IBA 02/2009 - 06/2007
2	Carcinoembryonic AntigenIBA 10/2007 - 02/2002
2	Death-Associated Protein KinasesIBA 07/2004 - 09/2002
2	poly(dG-dA)n.poly(dC-dT)n (((GA)n))IBA 05/2003 - 04/2003
1	TropomyosinIBA 12/2021
1	Alanine Transaminase (SGPT)IBA 12/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2021
1	Immune Checkpoint InhibitorsIBA 09/2020
1	theasinensin AIBA 07/2020
1	2- (2- methyl- 4- chlorophenylamino)- 2- imidazoline (CDMI)IBA 06/2020

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 11/2021 - 08/2011
10	Therapeutics 11/2021 - 01/2005
9	Adjuvant Chemotherapy 03/2022 - 08/2011
6	Chemoradiotherapy 01/2021 - 08/2011
4	Neoadjuvant Therapy 01/2021 - 01/2014
2	Immunotherapy 09/2020 - 01/2016
2	Radiotherapy 11/2018 - 08/2010
2	Combination Drug Therapy (Combination Chemotherapy) 06/2011 - 12/2010
1	Lasers (Laser) 01/2021
1	Ligation 07/2020